
Veradermics Completes Enrollment in Second Pivotal Phase 3 Trial of VDPHL01 for Male Pattern Hair Loss
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing…












